v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (29,185,898) $ (20,627,721)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 885,965 707,572
Stock compensation 5,087,315 4,022,656
Stock consideration issued to vendor 241,200 184,000
Amortization of debt discount 0 1,224,472
Convertible debt premium satisfied with common stock 0 200,000
Change in fair value of contingent consideration 752,429 (270,936)
Provision for credit losses 2,481,539 4,783,357
Loss on impairment of goodwill 0 433,556
Gain on expiration of accrued tax liability 0 (2,090,978)
Changes in operating assets and liabilities, net of amounts acquired or assumed in connection with acquisition:    
Accounts receivable (1,376,743) (3,897,875)
Other receivables (303,994) (60,660)
Inventories (568,960) (454,071)
Prepaid expenses and other current assets 726,900 (722,147)
Noncurrent receivables 58,365 35,883
Accounts payable 691,271 2,822,813
Noncurrent payables (48,888) (71,646)
Accounts payable and accrued liabilities - related parties 12,254,613 7,936,820
Accrued liabilities 199,236 640,529
Accrued payroll taxes, penalties and interest 0 35,242
Deferred revenue 231,890 556,336
Net cash used in operating activities (7,873,760) (4,612,798)
Cash flows from investing activities:    
Purchase of property and equipment (434,845) (693,201)
Purchase of intangibles (117,813) (470,680)
Acquisition of business, net of cash 0 100,454
Net cash used in investing activities (552,658) (1,063,427)
Cash flows from financing activities:    
Proceeds from related party notes payable 2,923,418 6,757,688
Repayments of related party notes payable (428,924) 350,028
Repayments of convertible note payable 0 (1,680,000)
Proceeds from notes payable 6,211,058 0
Repayments of notes payable (1,243,953) 0
Net proceeds (repayments) from notes payable 0 289,428
Proceeds from private placement 604,001 0
Net cash provided by financing activities 8,065,600 5,717,144
Net change in cash and cash equivalents (360,818) 40,919
Effect of exchange rate changes on cash 49,939 (175)
Cash and cash equivalents at beginning of period 812,806 772,062
Cash and cash equivalents at end of period 501,927 812,806
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 0 139,941
Cash paid for interest 621,735 9,048
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of related party notes and interest into preferred stock 14,878,016 33,859,544
Conversion of accounts payable-related parties to note payable-related parties 2,365,426 8,676,605
Common stock issued pursuant to business combination 70,936 314,475
Conversion of convertible note payable, accrued interest and premium into common stock 0 1,447,488
Warrants issued pursuant to acquisitions 22,722 0
Net assets acquired upon acquisition 371,298 0
(Decrease) Increase in right-of-use asset and liability $ (58,227) $ 2,227,830